ClearanceBrief
Recall Z-0205-2026 · DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control

Diagnostica Stago, Inc.

Product: STA Liatest D-Di; REF: 00515;

DateOct 16, 2025 (initiated Sep 12, 2025)
StatusOpen, Classified
ReasonA potential risk of underestimation of D-Dimer (D-Di) levels with the two listed lots.
Root causeUnder Investigation by firm
ActionOn September 12, 2025 URGENT: MEDICAL DEVICE RECALL (REMOVAL) letters were emailed to customers. Actions for customers: Discontinue use of affected lots and dispose of them in accordance with your local regulations. Complete and return response form. For additional information, please contact Stago's 24/7 Hotline at 1-800-725-0607.
Quantity12740 units
DistributionWorldwide distribution- US Nationwide and the country of Canada.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K141144STA LIATEST D-DI
Diagnostica Stago, Sep 3, 2014
K162227STA® - Liatest® D-Di
Diagnostica Stago, Dec 10, 2016
K964728STA-LIATEST D-DI TEST KIT
American Bioproducts Co., Jun 26, 1997